Free Trial

William Blair Weighs in on RLI's Q4 Earnings (NYSE:RLI)

RLI logo with Finance background

RLI Corp. (NYSE:RLI - Free Report) - Equities research analysts at William Blair boosted their Q4 2025 earnings per share (EPS) estimates for shares of RLI in a research report issued on Wednesday, July 23rd. William Blair analyst A. Klauber now forecasts that the insurance provider will post earnings per share of $0.87 for the quarter, up from their prior estimate of $0.83. The consensus estimate for RLI's current full-year earnings is $3.08 per share.

A number of other brokerages have also recently issued reports on RLI. Wall Street Zen raised shares of RLI from a "sell" rating to a "hold" rating in a report on Saturday. JMP Securities reaffirmed a "market perform" rating on shares of RLI in a report on Thursday, April 24th. Compass Point cut shares of RLI from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, Keefe, Bruyette & Woods dropped their target price on shares of RLI from $95.00 to $85.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, RLI currently has a consensus rating of "Hold" and a consensus price target of $78.60.

Get Our Latest Analysis on RLI

RLI Stock Performance

Shares of RLI stock traded down $0.00 on Thursday, reaching $67.78. The stock had a trading volume of 846,174 shares, compared to its average volume of 742,861. The company has a quick ratio of 0.35, a current ratio of 0.34 and a debt-to-equity ratio of 0.06. The firm's 50-day moving average is $72.62 and its two-hundred day moving average is $74.70. The firm has a market capitalization of $6.22 billion, a price-to-earnings ratio of 19.42 and a beta of 0.67. RLI has a 12 month low of $67.12 and a 12 month high of $91.14.

RLI (NYSE:RLI - Get Free Report) last issued its quarterly earnings results on Monday, July 21st. The insurance provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.75 by $0.09. RLI had a net margin of 17.81% and a return on equity of 15.82%. The firm had revenue of $562.28 million for the quarter, compared to analysts' expectations of $445.55 million. During the same period in the previous year, the firm posted $1.72 EPS. The company's revenue for the quarter was up 20.0% on a year-over-year basis.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Chung Wu Investment Group LLC acquired a new position in RLI during the second quarter worth about $29,000. Golden State Wealth Management LLC boosted its position in RLI by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 372 shares of the insurance provider's stock valued at $30,000 after buying an additional 186 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in RLI by 100.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 396 shares of the insurance provider's stock valued at $32,000 after buying an additional 198 shares in the last quarter. Versant Capital Management Inc boosted its position in RLI by 100.0% in the first quarter. Versant Capital Management Inc now owns 406 shares of the insurance provider's stock valued at $33,000 after buying an additional 203 shares in the last quarter. Finally, Ameritas Advisory Services LLC acquired a new stake in RLI in the second quarter valued at approximately $37,000. 77.89% of the stock is owned by institutional investors.

Insider Activity at RLI

In other RLI news, COO Jennifer L. Klobnak bought 3,000 shares of the stock in a transaction dated Thursday, July 24th. The shares were bought at an average cost of $69.15 per share, with a total value of $207,450.00. Following the completion of the acquisition, the chief operating officer owned 98,450 shares of the company's stock, valued at $6,807,817.50. This trade represents a 3.14% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 2.16% of the company's stock.

RLI Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, May 30th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, May 30th. This is a boost from RLI's previous quarterly dividend of $0.15. This represents a $0.64 annualized dividend and a dividend yield of 0.94%. RLI's dividend payout ratio (DPR) is currently 18.34%.

About RLI

(Get Free Report)

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile.

Further Reading

Earnings History and Estimates for RLI (NYSE:RLI)

Should You Invest $1,000 in RLI Right Now?

Before you consider RLI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RLI wasn't on the list.

While RLI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines